Natural resistance against infections: focus on COVID-19

被引:14
|
作者
Netea, Mihai G. [1 ,2 ,3 ]
Dominguez-Andres, Jorge [1 ,2 ]
van de Veerdonk, Frank L. [1 ,2 ]
van Crevel, Reinout [1 ,2 ,4 ]
Pulendran, Bali [5 ,6 ]
van der Meer, Jos W. M. [1 ,2 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands
[3] Univ Bonn, Life & Med Sci Inst, Dept Immunol & Metab, Bonn, Germany
[4] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England
[5] Stanford Univ, Sch Med, Inst Immunol Transplantat & Infect Dis, Dept Pathol, Stanford, CA 94305 USA
[6] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA
基金
美国国家卫生研究院; 欧洲研究理事会;
关键词
IMMUNITY; TOLERANCE; HIV;
D O I
10.1016/j.it.2021.12.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Not all individuals exposed to a pathogen develop illness: some are naturally resistant whereas others develop an asymptomatic infection. Epidemiological studies suggest that there is similar variability in susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. We propose that natural resistance is part of the disease history in some individuals exposed to this new coronavirus. Epidemiological arguments for natural resistance to SARS-CoV-2 are the lower seropositivity of children compared to adults, studies on closed environments of ships with outbreaks, and prevalence studies in some developing countries. Potential mechanisms of natural resistance include host genetic variants, viral interference, cross-protective natural antibodies, T cell immunity, and highly effective innate immune responses. Better understanding of natural resistance can help to advance preventive and therapeutic measures against infections for improved preparedness against potential future pandemics.
引用
收藏
页码:106 / 116
页数:11
相关论文
共 50 条
  • [21] The Assessment of Convalescent Plasma Efficacy against COVID-19
    Casadevall, Arturo
    Grossman, Brenda J.
    Henderson, Jeffrey P.
    Joyner, Michael J.
    Shoham, Shmuel
    Pirofski, Liise-Anne
    Paneth, Nigel
    MED, 2020, 1 (01): : 66 - 77
  • [22] The Lawsuit against the United States for Causing COVID-19
    Limsira, Patthara
    JOURNAL OF EAST ASIA AND INTERNATIONAL LAW, 2020, 13 (02) : 233 - 245
  • [23] Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
    Remy, Kenneth E.
    Mazer, Monty
    Striker, David A.
    Ellebedy, Ali H.
    Walton, Andrew H.
    Unsinger, Jacqueline
    Blood, Teresa M.
    Mudd, Philip A.
    Yi, Daehan J.
    Mannion, Daniel A.
    Osborne, Dale F.
    Martin, R. Scott
    Anand, Nitin J.
    Bosanquet, James P.
    Blood, Jane
    Drewry, Anne M.
    Caldwell, Charles C.
    Turnbull, Isaiah R.
    Brakenridge, Scott C.
    Moldwawer, Lyle L.
    Hotchkiss, Richard S.
    JCI INSIGHT, 2020, 5 (17)
  • [24] Safety and Efficacy of the Common Vaccines against COVID-19
    Liu, Ying
    Ye, Qing
    VACCINES, 2022, 10 (04)
  • [25] Editor's choice: COVID-19 and other infections in Africa
    Tumwine, James K.
    AFRICAN HEALTH SCIENCES, 2023, 23 (01) : I - V
  • [26] COVID-19 infections and effectiveness of the vaccination among healthcare workers
    Bernadette, Rojkovich
    Dora, Nemeth
    Elek, Dinya
    Erzsebet, Nagy
    Eszter, Toeroek
    Imre, Lazar
    Andras, Perduk
    Pal, Geher
    Gyorgy, Nagy
    ORVOSI HETILAP, 2023, 164 (05) : 163 - 171
  • [27] Engineering a dual vaccine against COVID-19 and tuberculosis
    Guthrie, Carlyn Monet
    Tan, Xuejuan
    Meeker, Amber Cherry
    Self, Ashton Elisabeth
    Liu, Lin
    Cheng, Yong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [29] COVID-19 reinfection: the role of natural immunity, vaccines, and variants
    Sciscent, Bao Y.
    Eisele, Caroline D.
    Ho, Lisa
    King, Steven D.
    Jain, Rohit
    Golamari, Reshma R.
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2021, 11 (06): : 733 - 739
  • [30] Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
    Amanatidou, Evropi
    Gkiouliava, Anna
    Pella, Eva
    Serafidi, Maria
    Tsilingiris, Dimitrios
    Vallianou, Natalia G.
    Karampela, I. rene
    Dalamaga, Maria
    METABOLISM OPEN, 2022, 14